Bristol Myers Squibb (BMS)

This page displays all content tagged with this topic. If you're looking for more specific information, please use the search page for advanced filtering.

The 2025 Continent 2 Continent 4 Cancer (C2C4C) Japan cycling event wraps up!

C2C4C Europe ride opens, uniting Bristol Myers Squibb employees across 19 countries to raise funds for cancer organisations

Fundraising for Bristol Myers Squibb’s C2C4C cycling events opens

Group of cyclists from Japan in BMS branded pink shirts facing Mount Fuji with arms raised, backs to the camera

The C2C4C Latin American ride 2024: significant support for cancer research and awareness in the region

Cyclists in white and purple jerseys and black shorts posing on a beach in Chile

European C2C4C ride kicks off on 6 September

Group of cyclist in white and dark pink jerseys with the tower of a bridge in the background

Bristol Myers Squibb extends its longstanding commitment to cancer research through the C2C4C ride in Latin America

Commemorating a decade of Bristol Myers Squibb employees cycling for cancer research

Group of cyclists on a road through a corn field, with t-shirts featuring Bristol Myers Squibb (BMS) and the Country 2 Country 4 Cancer ride

On 19 September, employees of Bristol Myers Squibb will have cycled 2,200km across Europe in support of cancer research and cancer organisations. On 15 September, fundraising starts for a new C2C4C ride organised by Bristol Myers Squibb in Latin America.

Author(s):

Union for International Cancer Control (UICC)

Download (

798.41 KB

)

More epic cycling rides in 2022 by BMS to fundraise for UICC members

Employees of Bristol Myers Squibb riding for the Ger Power Irish team in the 2021 Country to Country for Cancer ride